Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane.

Source:http://linkedlifedata.com/resource/pubmed/id/17693997

Download in:

View as

General Info

PMID
17693997